Advanced search
Publication Cover
Infection and Drug Resistance Volume 15, 2022 - Issue
Submit an article Journal homepage
159
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Clinical Characteristics, Microbiology, and Risk Factors for Mortality of Pre-Engraftment and Post-Engraftment Bloodstream Infection in Hematopoietic Stem Cell Transplantation Recipients

Weihao Chen1 Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China;2 Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, 311121, People’s Republic of China;3 Institute of Hematology, Zhejiang University, Hangzhou, People’s Republic of China;4 Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, People’s Republic of ChinaView further author information
,
Yanmin Zhao1 Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China;2 Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, 311121, People’s Republic of China;3 Institute of Hematology, Zhejiang University, Hangzhou, People’s Republic of China;4 Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, People’s Republic of ChinaView further author information
,
Yi Luo1 Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China;2 Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, 311121, People’s Republic of China;3 Institute of Hematology, Zhejiang University, Hangzhou, People’s Republic of China;4 Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, People’s Republic of ChinaView further author information
,
Jian Yu1 Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China;2 Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, 311121, People’s Republic of China;3 Institute of Hematology, Zhejiang University, Hangzhou, People’s Republic of China;4 Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, People’s Republic of ChinaView further author information
,
Huarui Fu1 Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China;2 Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, 311121, People’s Republic of China;3 Institute of Hematology, Zhejiang University, Hangzhou, People’s Republic of China;4 Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, People’s Republic of ChinaView further author information
,
Xiaoyu Lai1 Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China;2 Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, 311121, People’s Republic of China;3 Institute of Hematology, Zhejiang University, Hangzhou, People’s Republic of China;4 Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, People’s Republic of ChinaView further author information
,
Lizhen Liu1 Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China;2 Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, 311121, People’s Republic of China;3 Institute of Hematology, Zhejiang University, Hangzhou, People’s Republic of China;4 Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, People’s Republic of ChinaView further author information
,
Yishan Ye1 Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China;2 Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, 311121, People’s Republic of China;3 Institute of Hematology, Zhejiang University, Hangzhou, People’s Republic of China;4 Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, People’s Republic of ChinaView further author information
,
Jingsong He1 Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China;2 Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, 311121, People’s Republic of China;3 Institute of Hematology, Zhejiang University, Hangzhou, People’s Republic of China;4 Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, People’s Republic of ChinaView further author information
,
Jie Sun1 Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China;2 Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, 311121, People’s Republic of China;3 Institute of Hematology, Zhejiang University, Hangzhou, People’s Republic of China;4 Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, People’s Republic of ChinaView further author information
,
Weiyan Zheng1 Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China;2 Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, 311121, People’s Republic of China;3 Institute of Hematology, Zhejiang University, Hangzhou, People’s Republic of China;4 Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, People’s Republic of ChinaView further author information
,
Yi Zhao1 Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China;2 Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, 311121, People’s Republic of China;3 Institute of Hematology, Zhejiang University, Hangzhou, People’s Republic of China;4 Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, People’s Republic of ChinaView further author information
,
Guoqing Wei1 Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China;2 Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, 311121, People’s Republic of China;3 Institute of Hematology, Zhejiang University, Hangzhou, People’s Republic of China;4 Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, People’s Republic of ChinaView further author information
,
Zhen Cai1 Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China;2 Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, 311121, People’s Republic of China;3 Institute of Hematology, Zhejiang University, Hangzhou, People’s Republic of China;4 Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, People’s Republic of ChinaView further author information
,
He Huang1 Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China;2 Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, 311121, People’s Republic of China;3 Institute of Hematology, Zhejiang University, Hangzhou, People’s Republic of China;4 Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, People’s Republic of ChinaView further author information
&
Jimin Shi1 Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China;2 Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, 311121, People’s Republic of China;3 Institute of Hematology, Zhejiang University, Hangzhou, People’s Republic of China;4 Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, People’s Republic of ChinaCorrespondence[email protected] [email protected]
View further author information
 show all
Pages 6893-6905 | Received 15 Oct 2022, Accepted 16 Nov 2022, Published online: 28 Nov 2022

References

  • Ustun C, Young J-AH, Papanicolaou GA, et al. Bacterial blood stream infections (BSIs), particularly post-engraftment BSIs, are associated with increased mortality after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2019;54:1254–1265. doi:10.1038/s41409-018-0401-4
  • Busca A, Cavecchia I, Locatelli F, et al. Blood stream infections after allogeneic stem cell transplantation: a single-center experience with the use of levofloxacin prophylaxis. Transpl Infect Dis. 2012;14:40–48. doi:10.1111/j.1399-3062.2011.00650.x
  • Gudiol C, Garcia-Vidal C, Arnan M, et al. Etiology, clinical features and outcomes of pre-engraftment and post-engraftment bloodstream infection in hematopoietic SCT recipients. Bone Marrow Transplant. 2014;49:824–830. doi:10.1038/bmt.2014.37
  • Hong J, Moon SM, Ahn HK, et al. Comparison of characteristics of bacterial bloodstream infection between adult patients with allogeneic and autologous hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2013;19:994–999. doi:10.1016/j.bbmt.2013.03.019
  • Poutsiaka DD, Price LL, Ucuzian A, et al. Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality. Bone Marrow Transplant. 2007;40:63–70. doi:10.1038/sj.bmt.1705690
  • Mikulska M, Del Bono V, Bruzzi P, et al. Mortality after bloodstream infections in allogeneic haematopoietic stem cell transplant (HSCT) recipients. Infection. 2012;40:271–278. doi:10.1007/s15010-011-0229-y
  • Yan CH, Wang Y, Mo X-D, et al. Incidence, risk factors, microbiology and outcomes of pre-engraftment bloodstream infection after haploidentical hematopoietic stem cell transplantation and comparison with HLA-identical sibling transplantation. Clin Infect Dis. 2018;67:S162–s173. doi:10.1093/cid/ciy658
  • Akinboyo IC, Young RR, Spees LP, et al. Microbiology and risk factors for hospital-associated bloodstream infections among pediatric hematopoietic stem cell transplant recipients. Open Forum Infect Dis. 2020;7:ofaa093. doi:10.1093/ofid/ofaa093
  • Poutsiaka DD, Munson D, Price LL, Chan GW, Snydman DR. Blood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associated. Bone Marrow Transplant. 2011;46:300–307. doi:10.1038/bmt.2010.112
  • Meyer E, Beyersmann J, Bertz H, et al. Risk factor analysis of blood stream infection and pneumonia in neutropenic patients after peripheral blood stem-cell transplantation. Bone Marrow Transplant. 2007;39:173–178. doi:10.1038/sj.bmt.1705561
  • Junghanss C, Marr KA, Carter RA, et al. Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study. Biol Blood Marrow Transplant. 2002;8:512–520. doi:10.1053/bbmt.2002.v8.pm12374456
  • Almyroudis NG, Fuller A, Jakubowski A, et al. Pre- and post-engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients. Transpl Infect Dis. 2005;7:11–17. doi:10.1111/j.1399-3062.2005.00088.x
  • Puerta-Alcalde P, Cardozo C, Marco F, et al. Changing epidemiology of bloodstream infection in a 25-years hematopoietic stem cell transplant program: current challenges and pitfalls on empiric antibiotic treatment impacting outcomes. Bone Marrow Transplant. 2020;55:603–612. doi:10.1038/s41409-019-0701-3
  • Weisser M, Theilacker C, Tschudin Sutter S, et al. Secular trends of bloodstream infections during neutropenia in 15 181 haematopoietic stem cell transplants: 13-year results from a European multicentre surveillance study (ONKO-KISS). Clin Microbiol Infect. 2017;23:854–859. doi:10.1016/j.cmi.2017.03.020
  • Hu FP, Guo Y, Zhu D-M, et al. Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005–2014. Clin Microbiol Infect. 2016;22(Suppl 1):S9–14. doi:10.1016/j.cmi.2016.01.001
  • Heston SM, Young RR, Hong H, et al. Microbiology of bloodstream infections in children after hematopoietic stem cell transplantation: a single-center experience over two decades (1997–2017). Open Forum Infect Dis. 2020;7:ofaa465. doi:10.1093/ofid/ofaa465
  • Luo Y, Xiao H, Lai X, et al. T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT. Blood. 2014;124:2735–2743. doi:10.1182/blood-2014-04-571570
  • Kikuchi M, Akahoshi Y, Nakano H, et al. Risk factors for pre- and post-engraftment bloodstream infections after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2015;17:56–65. doi:10.1111/tid.12345
  • Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52:e56–93. doi:10.1093/cid/cir073
  • Przepiorka D, Weisdorf D, Martin P, et al. 1994 consensus conference on acute GVHD grading. Bone Marrow Transplant. 1995;15:825–828.
  • Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268–281. doi:10.1111/j.1469-0691.2011.03570.x
  • Averbuch D, Tridello G, Hoek J, et al. Antimicrobial resistance in gram-negative rods causing bacteremia in hematopoietic stem cell transplant recipients: intercontinental prospective study of the infectious diseases working party of the European Bone Marrow Transplantation Group. Clin Infect Dis. 2017;65:1819–1828. doi:10.1093/cid/cix646
  • Henriquez-Camacho C, Losa J. Biomarkers for sepsis. Biomed Res Int. 2014;2014:547818. doi:10.1155/2014/547818
  • Limper M, de Kruif MD, Duits AJ, Brandjes DP, van Gorp EC. The diagnostic role of procalcitonin and other biomarkers in discriminating infectious from non-infectious fever. J Infect. 2010;60:409–416. doi:10.1016/j.jinf.2010.03.016
  • Schuetz P, Albrich W, Mueller B. Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Med. 2011;9:107. doi:10.1186/1741-7015-9-107
  • Dandona P, Nix D, Wilson MF, et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab. 1994;79:1605–1608. doi:10.1210/jcem.79.6.7989463
  • Manian FA. Use of procalcitonin to guide duration of antimicrobial therapy in intensive care units: proceed with caution. Clin Infect Dis. 2012;54:578. doi:10.1093/cid/cir888
  • Bruno B, Busca A, Vallero S, et al. Current use and potential role of procalcitonin in the diagnostic work up and follow up of febrile neutropenia in hematological patients. Expert Rev Hematol. 2017;10:543–550. doi:10.1080/17474086.2017.1326813
  • Ji J, Klaus J, Burnham JP, et al. Bloodstream infections and delayed antibiotic coverage are associated with negative hospital outcomes in hematopoietic stem cell transplant recipients. Chest. 2020;158:1385–1396. doi:10.1016/j.chest.2020.06.011
  • Liu VX, Fielding-Singh V, Greene JD, et al. The timing of early antibiotics and hospital mortality in sepsis. Am J Respir Crit Care Med. 2017;196:856–863. doi:10.1164/rccm.201609-1848OC
  • Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62:e51–77. doi:10.1093/cid/ciw118
  • Graber CJ, de Almeida K, Atkinson JC, et al. Dental health and viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant. 2001;27:537–542. doi:10.1038/sj.bmt.1702818
  • Raad I, Chaftari AM. Advances in prevention and management of central line-associated bloodstream infections in patients with cancer. Clin Infect Dis. 2014;59(Suppl 5):S340–343. doi:10.1093/cid/ciu670
  • Mikulska M, Del Bono V, Raiola AM, et al. Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance. Biol Blood Marrow Transplant. 2009;15:47–53. doi:10.1016/j.bbmt.2008.10.024
  • Senol E, DesJardin J, Stark PC, Barefoot L, Snydman DR. Attributable mortality of Stenotrophomonas maltophilia bacteremia. Clin Infect Dis. 2002;34:1653–1656. doi:10.1086/340707
  • Nordmann P, Poirel L. Epidemiology and diagnostics of carbapenem resistance in gram-negative bacteria. Clin Infect Dis. 2019;69:S521–s528. doi:10.1093/cid/ciz824
  • Schwaber MJ, Carmeli Y. An ongoing national intervention to contain the spread of carbapenem-resistant Enterobacteriaceae. Clin Infect Dis. 2014;58:697–703. doi:10.1093/cid/cit795
  • Banerjee R, Humphries R. Clinical and laboratory considerations for the rapid detection of carbapenem-resistant Enterobacteriaceae. Virulence. 2017;8:427–439. doi:10.1080/21505594.2016.1185577
  • Yang TT, Luo X-P, Yang Q, et al. Different screening frequencies of carbapenem-resistant Enterobacteriaceae in patients undergoing hematopoietic stem cell transplantation: which one is better? Antimicrob Resist Infect Control. 2020;9:49. doi:10.1186/s13756-020-0706-0
  • Forcina A, Baldan R, Marasco V, et al. Control of infectious mortality due to carbapenemase-producing Klebsiella pneumoniae in hematopoietic stem cell transplantation. Bone Marrow Transplant. 2017;52:114–119. doi:10.1038/bmt.2016.234
  • Josa DF, Bustos G, Torres IC, Esparza SG. Evaluación de tres métodos de tamizaje para detección de Enterobacteriaceae productoras de carbapenemasas en hisopados rectales [Evaluation of three screening methods for detection of carbapenemase-producing Enterobacteriaceae in rectal swabs]. Rev Chilena Infectol. 2018;35:253–261. Spanish. doi:10.4067/s0716-10182018000300253
  • Traczewski MM, Carretto E, Canton R, Moore NM. Multicenter evaluation of the Xpert Carba-R assay for detection of carbapenemase genes in gram-negative isolates. J Clin Microbiol. 2018;56. doi:10.1128/jcm.00272-18

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.